Nutrineal Solution for Peritoneal Dialysis 4 with 1.1% amino acids

Home
Medicines
Nutrineal Solution for Peritoneal Dialysis 4 with 1.1% amino acids

Summary of Product Characteristics last updated on medicines.ie: 2/4/2019

Click on this link to Download PDF directly

Company Products

Medicine Name	Active Ingredients
Medicine Name 0.18% w/v Sodium Chloride and 4.0% w/v Glucose Intravenous Infusion BP, (Viaflo Container)	Active Ingredients Glucose Monohydrate, Sodium Chloride
Medicine Name ARTISS Solutions for Sealant	Active Ingredients Aprotinin, Calcium Chloride, Human Fibrinogen, Human Thrombin
Medicine Name Brevibloc Premixed 10 mg/ml Solution for Infusion	Active Ingredients Esmolol hydrochloride
Medicine Name Brevibloc Premixed 10 mg/ml Solution for Injection	Active Ingredients Esmolol hydrochloride
Medicine Name Cernevit, Powder for Solution for Injection or Infusion	Active Ingredients Ascorbic Acid (Vitamin C), Colecalciferol (Vitamin D3), Cyanocobalamin (Vitamin B12), d-Biotin (Vitamin H), Dexpanthenol, Folic Acid, Nicotinamide, Pyridoxine Hydrochloride (Vitamin B6), Riboflavine (Vitamin B2), Vitamin A (Palmitate), Vitamin B1, Vitamin E (tocopherol)
Medicine Name Chlorhexidine Acetate 0.015% w/v and Cetrimide 0.15% w/v Irrigation Solution	Active Ingredients Cetrimide, Chlorhexidine Acetate
Medicine Name Chlorhexidine Acetate BP 0.05% w/v Irrigation Solution	Active Ingredients Chlorhexidine Acetate
Medicine Name CLINIMIX N14G30E, solution for infusion	Active Ingredients Alanine, Arginine, Calcium Chloride, Glucose Monohydrate, Glycine, Histidine, Isoleucine, Leucine, Lysine, Magnesium chloride, Methionine, Phenylalanine, Potassium phosphate dibasic, Proline, Serine, Sodium acetate, trihydrate, Sodium Chloride, Threonine, Tryptophan, Tyrosine, Valine
Medicine Name Compound Sodium Lactate Solution for Infusion BP	Active Ingredients Calcium Chloride Dihydrate, Potassium Chloride, Sodium Chloride, Sodium Lactate
Medicine Name Dianeal PD4 Glucose 1.36% w/v (13.6 mg/ml), Solution for peritoneal dialysis	Active Ingredients Calcium Chloride Dihydrate, Glucose Monohydrate, Magnesium chloride, hexahydrate, Sodium Chloride, Sodium Lactate
Medicine Name Dianeal PD4 Glucose 2.27% w/v (22.7 mg/ml), Solution for peritoneal dialysis	Active Ingredients Calcium Chloride Dihydrate, Glucose Monohydrate, Magnesium chloride, hexahydrate, Sodium Chloride, Sodium Lactate
Medicine Name Dianeal PD4 Glucose 3.86% w/v (38.6 mg/ml), Solution for peritoneal dialysis	Active Ingredients Calcium Chloride Dihydrate, Glucose Monohydrate, Magnesium chloride, hexahydrate, Sodium Chloride, Sodium Lactate
Medicine Name Endoxana Coated Tablets 50 mg	Active Ingredients Cyclophosphamide monohydrate
Medicine Name EXTRANEAL (Icodextrin 7.5%) Solution for peritoneal dialysis	Active Ingredients Calcium Chloride, Icodextrin, Magnesium chloride, Sodium Chloride, Sodium Lactate
Medicine Name Finomel emulsion for infusion	Active Ingredients Alanine, Arginine, Calcium Chloride Dihydrate, Glucose Monohydrate, Glycine, Histidine, Isoleucine, Leucine, Lysine hydrochloride, Methionine, Phenylalanine, Potassium Chloride, Proline, Refined olive oil, Refined soybean oil, Serine, Sodium acetate, trihydrate, Sodium glycerophosphate, hydrated, Threonine, Tryptophan, Tyrosine, Valine, Zinc sulfate heptahydrate, Magnesium sulfate heptahydrate, Fish oil, rich in omega-3-acids, Medium-chain triglycerides
Medicine Name Finomel Peri emulsion for infusion	Active Ingredients Alanine, Arginine, Calcium Chloride Dihydrate, Glucose Monohydrate, Glycine, Histidine, Isoleucine, Leucine, Lysine hydrochloride, Methionine, Phenylalanine, Potassium Chloride, Proline, Refined olive oil, Refined soybean oil, Serine, Sodium acetate, trihydrate, Sodium glycerophosphate, hydrated, Threonine, Tryptophan, Tyrosine, Valine, Zinc sulfate heptahydrate, Magnesium sulfate heptahydrate, Fish oil, rich in omega-3-acids, Medium-chain triglycerides
Medicine Name Glucose 10% w/v Solution for Infusion	Active Ingredients Glucose Monohydrate
Medicine Name Glucose 5% Intravenous Infusion BP	Active Ingredients Glucose Monohydrate
Medicine Name Heparin Sodium BP 1000 IU/l in 0.9% w/v Sodium Chloride IV Infusion	Active Ingredients Citric Acid Monohydrate, Disodium Phosphate Dodecahydrate, Heparin Sodium, Sodium Chloride
Medicine Name Heparin Sodium BP 2000 IU/l in 0.9% w/v Sodium Chloride IV Infusion	Active Ingredients Citric Acid Monohydrate, Disodium Phosphate Dodecahydrate, Heparin Sodium, Sodium Chloride
Medicine Name Mannitol 10% Solution for Infusion BP	Active Ingredients Mannitol
Medicine Name Mannitol 15% w/v Solution for infusion	Active Ingredients Mannitol
Medicine Name Mitoxana 1 g Powder for Sterile Concentrate	Active Ingredients Ifosfamide
Medicine Name Mitoxana 2 g Powder for Sterile Concentrate	Active Ingredients Ifosfamide
Medicine Name Numeta G13%E Preterm, emulsion for infusion.	Active Ingredients Alanine, Arginine, Aspartic acid, Calcium Chloride Dihydrate, Cysteine, Glucose Monohydrate, Glutamic acid, Glycine, Histidine, Isoleucine, Leucine, Lysine, Magnesium acetate tetrahydrate, Methionine, Ornithine, Phenylalanine, Potassium acetate, Proline, Refined olive oil, Refined soybean oil, Serine, Sodium glycerophosphate, hydrated, Taurine, Threonine, Tryptophan, Tyrosine, Valine

Items Per Page :

1 - 0 of 67 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 2 April 2019 SmPC

Reasons for updating

Change to section 7 - Marketing authorisation holder
Change to section 8 - Marketing authorisation number(s)
Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 27 December 2017 PIL

Reasons for updating

Change to section 2 - Qualitative and quantitative composition
Change to section 4.8 - Undesirable effects
Change to section 6.4 - Special precautions for storage
Change to section 10 - Date of revision of the text

Free text change information supplied by the pharmaceutical company

Section 2 - change all qualitative and quantitative compositions and change Lysine chlorhydrate to Lysine Hydrochloride.

Section 4.8 - addition reporting of suspected adverse reactions statement.

Section 6.4 - change in storage instructions - Keep in outer carton in order to protect from light.

Updated on 27 December 2017 SmPC

Reasons for updating

Change to section 2 - Qualitative and quantitative composition
Change to section 4.8 - Undesirable effects
Change to section 6.4 - Special precautions for storage
Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Updated on 27 December 2017 SmPC

Reasons for updating

New SmPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 1 September 2016 PIL

Reasons for updating

New SPC for medicines.ie

Free text change information supplied by the pharmaceutical company

None provided

Updated on 1 September 2016 SmPC

Reasons for updating

New SPC for medicines.ie

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

None provided